Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anabolics coaching: Emic harm reduction or a public health concern?
Nick Gibbs, Luke Cox, Luke A. Turnock
Performance Enhancement & Health (2022) Vol. 10, Iss. 3, pp. 100227-100227
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

“They sent it away for testing and it was all bunk”: Exploring perspectives on drug checking among steroid consumers in Queensland, Australia
Timothy Piatkowski, Cheneal Puljević, Cameron Francis, et al.
International Journal of Drug Policy (2023) Vol. 119, pp. 104139-104139
Open Access | Times Cited: 32
“Emerging anabolic androgenic steroid markets; the prominence of social media”
Luke Cox, Nick Gibbs, Luke A. Turnock
Drugs Education Prevention and Policy (2023) Vol. 31, Iss. 2, pp. 257-270
Closed Access | Times Cited: 29
The Liver King Lie: Misrepresentation, justification, and public health implications
Nick Gibbs, Timothy Piatkowski
International Journal of Drug Policy (2023) Vol. 114, pp. 103979-103979
Open Access | Times Cited: 23
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 14
Exploring the role of community pharmacies as a harm reduction environment for anabolic–androgenic steroid consumers: triangulating the perspectives of consumers and pharmacists
Timothy Piatkowski, Sarah Benn, Lkhagvadulam Ayurzana, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
‘The general concept is a safer use approach’: how image and performance enhancing drug coaches negotiate safety through community care
Timothy Piatkowski, Luke Cox, Nick Gibbs, et al.
Drugs Education Prevention and Policy (2024), pp. 1-9
Closed Access | Times Cited: 13
Navigating Risks and Reducing Harm: A Gendered Analysis of Anabolic–Androgenic Steroid Users Within the Risk Environment Framework
Timothy Piatkowski, Matthew Dunn
Contemporary Drug Problems (2024) Vol. 51, Iss. 2, pp. 111-128
Open Access | Times Cited: 12
Click, click, buy: The market for novel synthetic peptide hormones on mainstream e-commerce platforms in the UK
Dr Luke Turnock, Nick Gibbs
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100251-100251
Open Access | Times Cited: 20
Polysubstance use practices among women using anabolic-androgenic steroids (AAS)
Timothy Piatkowski, Jonathan Robertson, Matthew Dunn
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100248-100248
Closed Access | Times Cited: 18
#Sponseredathlete: the marketing of image and performance enhancing drugs on Facebook and Instagram
Nick Gibbs
Trends in Organized Crime (2023)
Open Access | Times Cited: 18
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18
Social media influencers, YouTube & performance and image enhancing drugs: A narrative-typology
Luke Cox, Letizia Paoli
Performance Enhancement & Health (2023) Vol. 11, Iss. 4, pp. 100266-100266
Open Access | Times Cited: 16
The Enhanced Games or Enhancing Harm?
Andrew Richardson
Performance Enhancement & Health (2024) Vol. 12, Iss. 3, pp. 100285-100285
Open Access | Times Cited: 6
“More drugs means more stress on my body”: exploring enhancement and health among elite strength athletes who use performance and image enhancing drugs
Timothy Piatkowski, David L. Neumann, Carol A. Keane, et al.
Addiction Research & Theory (2023) Vol. 32, Iss. 5, pp. 333-338
Open Access | Times Cited: 15
Across the spectrum of legality: The market activities of influencers specialized in steroids and other performance and image enhancing drugs
Letizia Paoli, Luke Cox
International Journal of Drug Policy (2023) Vol. 123, pp. 104246-104246
Open Access | Times Cited: 13
“You Could Try This Compound, but it Might Send You nuts”: How Steroid Suppliers Perceive the Underground Market and Their ‘Hybrid’ Role within It
Timothy Piatkowski, Steve Vigorous, Luke Cox, et al.
Deviant Behavior (2024), pp. 1-12
Open Access | Times Cited: 5
Grow through what you go through: a multiple-case study of competitive bodybuilders’ experiences of learning to manage the demands of their engagement in the sport
Ellie F. Willmott, Sam N. Thrower, Andrea Petróczi
Qualitative Research in Sport Exercise and Health (2025), pp. 1-17
Open Access
If you find me on the floor, stick some sugar in my mouth : The social production (and protection) of insulin risk among IPED communities
Kim Akrigg, Luke Cox, Luke A. Turnock, et al.
Drugs Education Prevention and Policy (2025), pp. 1-12
Open Access
The ethics of enhancement among image and performance enhancing drug coaches
Timothy Piatkowski, Luke Cox, Rick Collins
Health Sociology Review (2024), pp. 1-15
Open Access | Times Cited: 4
Tracing the Impact of Media, Cultural Narratives, and Social Perceptions on Australia's Anabolic-Androgenic Steroid Communities
Timothy Piatkowski, Monica J. Barratt, Ross Coomber, et al.
Contemporary Drug Problems (2025)
Closed Access
Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 10
“I Feel Like I’m Walking the Line; One Side It’s Manageable, the Other Side It’s F**king prison”: exploring the Dual Nature of User-Manufacturers of Image and Performance Enhancing Drugs
Timothy Piatkowski, Nick Gibbs, Matthew Dunn
Deviant Behavior (2023) Vol. 45, Iss. 7, pp. 929-946
Closed Access | Times Cited: 9
From ‘bro, do you even lift?’ to ‘bro, do you even science?’: How the relationship between science and broscience can inform the development of allied image and performance enhancing drug harm reduction
Mair Underwood
Performance Enhancement & Health (2024), pp. 100291-100291
Open Access | Times Cited: 3
Rethinking Women’s “Performance and Image-Enhancing Drug Consumption”: An Agenda for Ontopolitically-Oriented Research
Renae Fomiatti, Kim Toffoletti, Kiran Pienaar
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 217-231
Open Access | Times Cited: 8
Novel wellbeing and repair peptide use in the UK: Netnographic findings
Luke A. Turnock, Evelyn Hearne
Performance Enhancement & Health (2024), pp. 100293-100293
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top